{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:58:38Z","timestamp":1712192318853},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,2]]},"DOI":"10.7759\/cureus.57487","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T04:54:05Z","timestamp":1712120045000},"source":"Crossref","is-referenced-by-count":0,"title":["Non-alcoholic Fatty Liver Disease Among Iraqi Patients With Psoriasis: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Samer A","family":"Dhaher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noora Z","family":"Hilfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muntadher A","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi R","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013, 133:377-85. 10.1038\/jid.2012.339","journal-title":"J Invest Dermatol"},{"key":"ref2","article-title":"The epidemiology of dermatological diseases in Al-Nasiriya City 2018","volume":"20","author":"Ibrahim ZJ","year":"2020","unstructured":"Ibrahim ZJ, Al-Ghuzi AA, Kawen AA. The epidemiology of dermatological diseases in Al-Nasiriya City 2018. Thi-Qar Medical Journal. 2020, 20:12-23.","journal-title":"Thi-Qar Medical Journal"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici BB","year":"2010","unstructured":"Davidovici BB, Sattar N, Prinz J, et al.. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010, 130:1785-96. 10.1038\/jid.2010.103","journal-title":"J Invest Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin CT","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017, 376:957-70. 10.1056\/NEJMra1505557","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03096","article-title":"IL-17A in psoriasis and beyond: cardiovascular and metabolic implications","volume":"10","author":"von Stebut E","year":"2019","unstructured":"von Stebut E, Boehncke WH, Ghoreschi K, Gori T, Kaya Z, Thaci D, Sch\u00e4ffler A. IL-17A in psoriasis and beyond: cardiovascular and metabolic implications. Front Immunol. 2019, 10:3096. 10.3389\/fimmu.2019.03096","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2012.02593.x","article-title":"Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study","volume":"273","author":"Ahlehoff O","year":"2013","unstructured":"Ahlehoff O, Skov L, Gislason G, et al.. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study. J Intern Med. 2013, 273:197-204. 10.1111\/j.1365-2796.2012.02593.x","journal-title":"J Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307449","article-title":"Nationwide study on the risk of abdominal aortic aneurysms in patients with psoriasis","volume":"36","author":"Khalid U","year":"2016","unstructured":"Khalid U, Egeberg A, Ahlehoff O, Smedegaard L, Gislason GH, Hansen PR. Nationwide study on the risk of abdominal aortic aneurysms in patients with psoriasis. Arterioscler Thromb Vasc Biol. 2016, 36:1043-8. 10.1161\/ATVBAHA.116.307449","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12663","article-title":"Prevalence of metabolic syndrome in Chinese psoriasis patients: a hospital-based cross-sectional study","volume":"9","author":"Gui XY","year":"2018","unstructured":"Gui XY, Yu XL, Jin HZ, Zuo YG, Wu C. Prevalence of metabolic syndrome in Chinese psoriasis patients: a hospital-based cross-sectional study. J Diabetes Investig. 2018, 9:39-43. 10.1111\/jdi.12663","journal-title":"J Diabetes Investig"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the metabolic syndrome","volume":"36","author":"Gisondi P","year":"2018","unstructured":"Gisondi P, Fostini AC, Foss\u00e0 I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol. 2018, 36:21-8. 10.1016\/j.clindermatol.2017.09.005","journal-title":"Clin Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2012.26","article-title":"The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong AW","year":"2012","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes. 2012, 2:e54. 10.1038\/nutd.2012.26","journal-title":"Nutr Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13688","article-title":"Evidence-based clinical\u00a0practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020","volume":"51","author":"Tokushige K","year":"2021","unstructured":"Tokushige K, Ikejima K, Ono M, et al.. Evidence-based clinical\u00a0practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. Hepatol Res. 2021, 51:1013-25. 10.1111\/hepr.13688","journal-title":"Hepatol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi ZM","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023, 77:1335-47. 10.1097\/HEP.0000000000000004","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2012.00905.x","article-title":"The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India","volume":"53","author":"Madanagobalane S","year":"2012","unstructured":"Madanagobalane S, Anandan S. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India. Australas J Dermatol. 2012, 53:190-7. 10.1111\/j.1440-0960.2012.00905.x","journal-title":"Australas J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88043-8","article-title":"Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients","volume":"11","author":"Belinch\u00f3n-Romero I","year":"2021","unstructured":"Belinch\u00f3n-Romero I, Bellot P, Romero-P\u00e9rez D, Herraiz-Romero I, Marco F, Frances R, Ramos-Rinc\u00f3n JM. Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients. Sci Rep. 2021, 11:8593. 10.1038\/s41598-021-88043-8","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2015.53376","article-title":"Relationship between psoriasis and non-alcoholic fatty liver disease","volume":"11","author":"Narayanasamy K","year":"2016","unstructured":"Narayanasamy K, Sanmarkan AD, Rajendran K, Annasamy C, Ramalingam S. Relationship between psoriasis and non-alcoholic fatty liver disease. Prz Gastroenterol. 2016, 11:263-9. 10.5114\/pg.2015.53376","journal-title":"Prz Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.10.044","article-title":"Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study","volume":"70","author":"van der Voort EA","year":"2014","unstructured":"van der Voort EA, Koehler EM, Dowlatshahi EA, et al.. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study. J Am Acad Dermatol. 2014, 70:517-24. 10.1016\/j.jaad.2013.10.044","journal-title":"J Am Acad Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12672","article-title":"Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease","volume":"40","author":"Abedini R","year":"2015","unstructured":"Abedini R, Salehi M, Lajevardi V, Beygi S. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease. Clin Exp Dermatol. 2015, 40:722-7. 10.1111\/ced.12672","journal-title":"Clin Exp Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.020","article-title":"Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Gisondi P","year":"2009","unstructured":"Gisondi P, Targher G, Zoppini G, Girolomoni G. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009, 51:758-64. 10.1016\/j.jhep.2009.04.020","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12847","article-title":"Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis","volume":"29","author":"Candia R","year":"2015","unstructured":"Candia R, Ruiz A, Torres-Robles R, Ch\u00e1vez-Tapia N, M\u00e9ndez-S\u00e1nchez N, Arrese M. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2015, 29:656-62. 10.1111\/jdv.12847","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000083509","article-title":"The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis","volume":"210","author":"Schmitt J","year":"2005","unstructured":"Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology. 2005, 210:194-9. 10.1159\/000083509","journal-title":"Dermatology"},{"key":"ref21","article-title":"Evaluation of liver function","author":"Daniels L","year":"2022","unstructured":"Daniels L, Khalili M, Goldstein E, Bluth MH, Bowne WB, Pincus MR. Evaluation of liver function. Henry's Clinical Diagnosis and Management by Laboratory Methods. McPherson RA, Pincus MR (ed): Elsevier, Philadelphia (PA); 2022."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy SM","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al.. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112:2735-52. 10.1161\/CIRCULATIONAHA.105.169404","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso M","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V, et al.. Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010, 36:1825-35. 10.1016\/j.ultrasmedbio.2010.07.005","journal-title":"Ultrasound Med Biol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong VW","year":"2010","unstructured":"Wong VW, Vergniol J, Wong GL, et al.. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010, 51:454-62. 10.1002\/hep.23312","journal-title":"Hepatology"},{"key":"ref25","article-title":"A case-control study to evaluate the prevalence of nonalcoholic fatty liver disease among patients with moderate-to-severe psoriasis","volume":"11","author":"Awosika O","year":"2018","unstructured":"Awosika O, Eleryan MG, Rengifo-Pardo M, Doherty L, Martin LW, Ehrlich A. A case-control study to evaluate the prevalence of nonalcoholic fatty liver disease among patients with moderate-to-severe psoriasis. J Clin Aesthet Dermatol. 2018, 11:33-7.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.1609","article-title":"Association between psoriasis and nonalcoholic fatty liver disease among outpatient US adults","volume":"158","author":"Ruan Z","year":"2022","unstructured":"Ruan Z, Lu T, Chen Y, Yuan M, Yu H, Liu R, Xie X. Association between psoriasis and nonalcoholic fatty liver disease among outpatient US adults. JAMA Dermatol. 2022, 158:745-53. 10.1001\/jamadermatol.2022.1609","journal-title":"JAMA Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.11.016","article-title":"The association between chronic plaque psoriasis and nonalcoholic fatty liver disease in Indian patients: results of a pilot study","volume":"12","author":"Mahajan VK","year":"2022","unstructured":"Mahajan VK, Chauhan NS, Rana BS, Mehta KS, Hooda S, Chauhan PS, Kukreja A. The association between chronic plaque psoriasis and nonalcoholic fatty liver disease in Indian patients: results of a pilot study. J Clin Exp Hepatol. 2022, 12:785-92. 10.1016\/j.jceh.2021.11.016","journal-title":"J Clin Exp Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13175","article-title":"Prevalence of non-alcoholic fatty liver and liver fibrosis in patients with moderate-severe psoriasis: a cross-sectional cohort study","volume":"61","author":"Magdaleno-Tapial J","year":"2020","unstructured":"Magdaleno-Tapial J, Valenzuela-O\u00f1ate C, Ortiz-Salvador JM, et al.. Prevalence of non-alcoholic fatty liver and liver fibrosis in patients with moderate-severe psoriasis: a cross-sectional cohort study. Australas J Dermatol. 2020, 61:105-9. 10.1111\/ajd.13175","journal-title":"Australas J Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms141020704","article-title":"Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)","volume":"14","author":"Takaki A","year":"2013","unstructured":"Takaki A, Kawai D, Yamamoto K. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int J Mol Sci. 2013, 14:20704-28. 10.3390\/ijms141020704","journal-title":"Int J Mol Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16239","article-title":"Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?","volume":"179","author":"Prussick RB","year":"2018","unstructured":"Prussick RB, Miele L. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?. Br J Dermatol. 2018, 179:16-29. 10.1111\/bjd.16239","journal-title":"Br J Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00910-2","article-title":"TNF in the liver: targeting a central player in inflammation","volume":"44","author":"Tiegs G","year":"2022","unstructured":"Tiegs G, Horst AK. TNF in the liver: targeting a central player in inflammation. Semin Immunopathol. 2022, 44:445-59. 10.1007\/s00281-022-00910-2","journal-title":"Semin Immunopathol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S272286","article-title":"Correlation between psoriasis severity and nonalcoholic fatty liver disease degree measured using controlled attenuation parameter","volume":"10","author":"Gandha N","year":"2020","unstructured":"Gandha N, Wibawa LP, Jacoeb TN, Sulaiman AS. Correlation between psoriasis severity and nonalcoholic fatty liver disease degree measured using controlled attenuation parameter. Psoriasis (Auckl). 2020, 10:39-44. 10.2147\/PTT.S272286","journal-title":"Psoriasis (Auckl)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/240271-non-alcoholic-fatty-liver-disease-among-iraqi-patients-with-psoriasis-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T04:54:08Z","timestamp":1712120048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/240271-non-alcoholic-fatty-liver-disease-among-iraqi-patients-with-psoriasis-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.57487","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,2]]}}}